This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec
Retrovirology Open Access 16 February 2009
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Braud, V. M. et al. Nature 391, 795–799 (1998).
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. & Brooks, A. G. J. Exp. Med. (in the press).
Lanier, L. L. Immunity 6, 371–378 (1997).
Braud, V. M., Allan, D. S. J., Wilson, D. & McMichael, A. J. Curr. Biol. 8, 1–10 (1998).
DeCloux, A. et al. J. Immunol. 158, 2183–2191 (1997).
Valiante, N. M. et al. Immunity 7, 739–751 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Long, E. Immunology Signal sequences stop killer cells. Nature 391, 741–743 (1998). https://doi.org/10.1038/35739
Issue Date:
DOI: https://doi.org/10.1038/35739
This article is cited by
-
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Bone Marrow Transplantation (2012)
-
Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec
Retrovirology (2009)
-
Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors
Nature Immunology (2003)